Scientists Offer Lab Space for Stranded Peers

Researchers in Europe and Canada are offering temporary bench and desk spaces to host scientists denied entry into the U.S. as a result of the President’s executive order on immigration.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, URCOMUNICACIONSome scientists and physicians are among those barred from coming—or returning—to the United States following an executive order from President Donald Trump, which temporarily prohibits some immigrants and refugees from entering the country. In response, numerous labs in Europe have offered to host waylaid researchers. Today (February 1), the European Molecular Biology Organization (EMBO) launched a website to help would-be hosts connect with stranded scientists.

“Everyone agrees we must do something,” Maria Leptin, EMBO’s director, told The Scientist. “It’s a feeling a solidarity with people who are stranded and with our colleagues in the U.S.”

Leptin was the first to join EMBO’s “Science Solidarity” list, offering to host stranded researchers in her own lab, based at the University of Cologne. Within an hour, scientists from Canada, Spain, the U.K., France, Switzerland, Germany, and Austria joined as sites willing to host travelers unable to enter the U.S.

Magnus Nordborg, a population geneticist at the Gregor Mendel Institute of Molecular Plant Biology, and Jürgen Kleine-Vehn, who studies plant growth at the University of Nature Resources and Life Sciences, both in Vienna, were among the first to make personal offers of lab space, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies